GNH USA

Europe — EMA

Methotrexate Accord

GNH USA supplies Methotrexate Accord (Methotrexate), a DMARD for rheumatoid arthritis, psoriasis, acute lymphoblastic leukemia and ectopic pregnancy.

Methotrexate

Request sourcing

1
Pack/s

What is Methotrexate?

Methotrexate, the active ingredient in Methotrexate Accord, is an antimetabolite presented as an injection for subcutaneous use. It modulates immune activity and cell proliferation, and is employed to treat rheumatoid arthritis, psoriasis, acute lymphoblastic leukemia and ectopic pregnancy in appropriate patient populations.

GNH USA supplies Methotrexate Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Methotrexate used for?

Methotrexate is a disease‑modifying antirheumatic drug that acts on rapidly dividing cells and immune pathways.

- Rheumatoid arthritis: reduces joint inflammation and slows disease progression. - Psoriasis: improves skin lesions and decreases plaque formation. - Acute lymphoblastic leukemia: interferes with malignant cell proliferation. - Ectopic pregnancy: terminates trophoblastic tissue and resolves the ectopic gestation.

What are the side effects of Methotrexate?

Methotrexate may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea and vomiting. - Fatigue. - Mouth ulcers. - Decreased white blood cell count.

Serious or Rare Side Effects: - Severe liver toxicity. - Pulmonary fibrosis. - Bone marrow suppression leading to anemia or pancytopenia.

What precautions apply to Methotrexate?

When prescribing methotrexate, several safety considerations should be observed.

- Pregnancy contraindication: Category X; avoid use in pregnant patients. - Liver monitoring: perform baseline and periodic liver function tests. - Hematologic monitoring: check complete blood counts regularly. - Renal function: avoid in severe renal impairment and adjust dose if needed. - Pulmonary assessment: evaluate for pre‑existing lung disease before initiation. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Methotrexate interact with?

Methotrexate can interact with other medicines, altering its efficacy or toxicity.

Major Interactions (Avoid): - Nonsteroidal anti‑inflammatory drugs (NSAIDs): increase risk of renal toxicity. - Live vaccines: may cause severe infection due to immunosuppression.

Moderate Interactions (Monitor Closely): - Trimethoprim‑sulfamethoxazole: may enhance myelosuppression. - Proton pump inhibitors: can affect methotrexate clearance. - Alcohol: may exacerbate liver toxicity.

Frequently asked questions

What is Methotrexate Accord used for?+
Methotrexate Accord contains methotrexate, which is indicated for the treatment of rheumatoid arthritis, moderate to severe plaque psoriasis, acute lymphoblastic leukemia, and medically managed ectopic pregnancy. It works by modulating immune activity and inhibiting rapidly dividing cells, helping to control inflammation and disease progression in these conditions.
How does methotrexate work?+
Methotrexate blocks the enzyme dihydrofolate reductase, preventing the formation of tetrahydrofolate needed for DNA synthesis. This antiproliferative action reduces the growth of immune cells and malignant cells, leading to decreased inflammation in autoimmune diseases and inhibition of cancer cell replication.
What is the usual dose of Methotrexate Accord?+
The dose of methotrexate is individualized and set by the prescribing clinician based on the specific indication, patient weight, renal function, and treatment response. Dosage regimens can vary widely, so the prescriber determines the appropriate amount and frequency.
Is Methotrexate Accord safe in pregnancy or breastfeeding?+
Methotrexate is classified as Pregnancy Category X, meaning it is contraindicated in pregnancy due to a high risk of fetal toxicity and malformations. It is also not recommended during breastfeeding because it can be excreted in breast milk and may harm the infant.
How do I order Methotrexate Accord from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity of Methotrexate Accord. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain logistics if needed) and required import documentation.
How does Methotrexate Accord compare with other DMARDs?+
Methotrexate is often considered the first‑line conventional DMARD because of its proven efficacy, oral or injectable formulations, and relatively low cost. Compared with newer biologic agents, it has a broader safety profile and does not require routine infusion, but it may be less rapid in controlling severe disease and requires regular laboratory monitoring.
What are the storage and handling requirements for Methotrexate Accord?+
Methotrexate Accord should be stored at 2‑8 °C in a refrigerator. Keep the product in its original packaging, protect it from light, and avoid freezing or shaking the vial. If temperature excursions occur, consult the supplier before use.
How is Methotrexate Accord administered?+
Methotrexate Accord is supplied for subcutaneous injection. The injection is typically performed by a healthcare professional using aseptic technique, and the dose is administered into the fatty tissue of the abdomen or thigh according to the prescriber’s instructions.
What are the most serious risks to watch for while using Methotrexate Accord?+
The most serious adverse events include severe liver toxicity, pulmonary fibrosis, and bone‑marrow suppression that can lead to anemia, leukopenia or thrombocytopenia. Patients should be monitored regularly for signs of liver dysfunction, respiratory symptoms, and abnormal blood counts, and therapy should be stopped if any of these conditions develop.
Who should not use Methotrexate Accord?+
Methotrexate is contraindicated in pregnant women, patients with severe renal or hepatic impairment, those with active infections, and individuals with known hypersensitivity to methotrexate or its excipients. Caution is also advised for patients with pre‑existing lung disease or a history of alcohol abuse.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Methotrexate
Route
Subcutaneous Use
Manufacturer
Accord Healthcare France Sas
Origin
EU

Related products

A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU